Evidence reviewed: October 2026
Minoxidil regrows thinning hair — whatever the cause.
Topical minoxidil can improve hair growth in male and female pattern hair loss. Response varies, takes months and generally requires continued treatment. It is not a universal remedy for every kind of hair loss.
Why has this claim become popular?
Before-and-after photographs make minoxidil look like a straightforward reversal of baldness. Unlike many cosmetic hair products, it has placebo-controlled human trials. The useful question is how much benefit is realistic, for whom, and at what cost in ongoing effort.
What does the scientific research show?
Controlled trials show genuine regrowth in men
Olsen and colleagues randomised 393 men aged 18–49 with androgenetic alopecia to 5% minoxidil, 2% minoxidil or vehicle twice daily for 48 weeks. The 5% solution performed better on non-vellus hair counts and patient and investigator assessments. Its hair-count regrowth was 45% greater than that with 2% at week 48. This relative difference does not mean 45% of lost hair returned or that 45% more people recovered a full head of hair.
Local itching and irritation were more frequent with 5%.
The broader evidence includes female pattern hair loss
Adil and Godwin’s systematic review and meta-analysis found minoxidil superior to placebo in the eligible good- and fair-quality trials, including evidence for women. Results varied substantially between studies. The Cochrane review of treatments for female pattern hair loss likewise supports topical minoxidil, while noting limitations in trial reporting and certainty. Evidence from male-pattern trials cannot simply determine the best strength or schedule for women; licensed formulations and directions differ.
Limitations and uncertainty
Hair counts are useful objective outcomes, but a statistically detectable increase may not produce the appearance someone hopes for. Participants, strengths, vehicles and follow-up differ. Advanced loss may respond poorly, and trial averages cannot identify an individual responder in advance. Much evidence concerns months of use rather than lifelong outcomes. This investigation concerns topical treatment: oral minoxidil has different systemic risks and prescribing considerations.
Trials in pattern hair loss do not establish effectiveness for sudden shedding, scarring alopecia or hair loss from an untreated illness.
What does this mean for you?
Confirm the cause if hair loss is sudden, patchy, painful or accompanied by scalp inflammation. Follow the relevant product directions rather than using extra amounts. British Association of Dermatologists information advises allowing months to assess response; initial shedding can occur, and ongoing use is needed to maintain benefit. Product information notes that gained hair can be lost within several months after stopping. Irritation and unwanted hair growth can occur.
Seek medical advice for dizziness, chest symptoms or swelling. Pregnancy, breastfeeding, age restrictions and cardiovascular concerns require the product-specific advice of a clinician or pharmacist.
If you are comparing options, read the investigation of rosemary oil versus minoxidil; apparent similarity in a small trial is not proof of equivalence.
The Evidence vs Hype verdict
Minoxidil is an evidence-based option for pattern hair loss. Expect a treatment commitment and variable improvement, rather than an instant or permanent cure.
Research & Sources
References were checked against journal, review, guideline or indexed research records. Where only an abstract was available, this review does not imply a full-text assessment.
- Olsen EA et al. (2002). A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in men. Journal of the American Academy of Dermatology. Original source ↗
- Adil A, Godwin M (2017). The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis. Journal of the American Academy of Dermatology. Original source ↗
- Cochrane review. Interventions for female pattern hair loss. Original source ↗
- British Association of Dermatologists. Male pattern hair loss. Original source ↗
- Electronic Medicines Compendium. Topical minoxidil patient leaflet. Original source ↗